Organization

AMBRY GENETICS CORPORATION

According to 2025 Medicare claims, AMBRY GENETICS CORPORATION (NPI: 1861568784) practices clinical laboratory (billing independently) in the Los Angeles-Long Beach-Glendale, CA market, with the plurality of this provider's patient population coming from Los Angeles, CA. This provider's primary affiliated billing organization is AMBRY GENETICS CORPORATION (NPI: 1861568784; TIN: 330892453) and primary practice location at 92656-1423. CORPORATION is affiliated with the UT Southwestern Accountable Care Network (ACO ID: D0211), participating under the REACH model.

The organization's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 30,047 traditional Medicare patients, billed 30,085 HCPCS/CPT codes, and received $52,841,770 in Medicare payments. The top billing code was 81479 (Molecular pathology procedure). No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, this provider has fewer than 5 years of reported Part D prescription costs data, so a reliable trend cannot be assigned. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.